Status: current, Defined. Date: 30-Apr 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4554111000168116 | Trientine (DRLA) (trientine dihydrochloride 250 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4554121000168111 | Trientine (DRLA) 250 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Trientine (DRLA) 250 mg capsule | Is a | trientine dihydrochloride 250 mg capsule | true | Inferred relationship | Some | ||
| Trientine (DRLA) 250 mg capsule | Is a | Trientine (DRLA) | true | Inferred relationship | Some | ||
| Trientine (DRLA) 250 mg capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Trientine (DRLA) 250 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| Trientine (DRLA) 250 mg capsule | has intended active ingredient | trientine | true | Inferred relationship | Some | 799529468 | |
| Trientine (DRLA) 250 mg capsule | has Australian BoSS | trientine dihydrochloride | true | Inferred relationship | Some | 799529468 | |
| Trientine (DRLA) 250 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 790541452 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Trientine (DRLA) 250 mg capsule, 100, bottle | has TPUU | True | Trientine (DRLA) 250 mg capsule | Inferred relationship | Some | 2122321481 |
| Trientine (DRLA) 250 mg capsule, 100 | has TPUU | True | Trientine (DRLA) 250 mg capsule | Inferred relationship | Some | 1581071930 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR